128 related articles for article (PubMed ID: 37981251)
1. The step-wise dissolution method: An efficient DSC-based protocol for verification of predicted API-polymer compatibility.
Mathers A; Pechar M; Hassouna F; Fulem M
Int J Pharm; 2023 Dec; 648():123604. PubMed ID: 37981251
[TBL] [Abstract][Full Text] [Related]
2. Comparative Study of DSC-Based Protocols for API-Polymer Solubility Determination.
Mathers A; Hassouna F; Klajmon M; Fulem M
Mol Pharm; 2021 Apr; 18(4):1742-1757. PubMed ID: 33656884
[TBL] [Abstract][Full Text] [Related]
3. Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug-Polymer Compatibility Screening?
Pavliš J; Mathers A; Fulem M; Klajmon M
Mol Pharm; 2023 Aug; 20(8):3960-3974. PubMed ID: 37386723
[TBL] [Abstract][Full Text] [Related]
4. Effect of Copolymer Properties on the Phase Behavior of Ibuprofen-PLA/PLGA Mixtures.
Iemtsev A; Klajmon M; Hassouna F; Fulem M
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839967
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
Mol Pharm; 2017 Jan; 14(1):157-171. PubMed ID: 28043133
[TBL] [Abstract][Full Text] [Related]
6. Physical stability of API/polymer-blend amorphous solid dispersions.
Lehmkemper K; Kyeremateng SO; Bartels M; Degenhardt M; Sadowski G
Eur J Pharm Biopharm; 2018 Mar; 124():147-157. PubMed ID: 29269154
[TBL] [Abstract][Full Text] [Related]
7. Moisture-induced phase separation and recrystallization in amorphous solid dispersions.
Luebbert C; Sadowski G
Int J Pharm; 2017 Oct; 532(1):635-646. PubMed ID: 28867448
[TBL] [Abstract][Full Text] [Related]
8. Thermodynamic phase behavior of API/polymer solid dispersions.
Prudic A; Ji Y; Sadowski G
Mol Pharm; 2014 Jul; 11(7):2294-304. PubMed ID: 24870944
[TBL] [Abstract][Full Text] [Related]
9. Physical stability of hydroxypropyl methylcellulose-based amorphous solid dispersions: Experimental and computational study.
Iemtsev A; Hassouna F; Mathers A; Klajmon M; Dendisová M; Malinová L; Školáková T; Fulem M
Int J Pharm; 2020 Nov; 589():119845. PubMed ID: 32931845
[TBL] [Abstract][Full Text] [Related]
10. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
Luebbert C; Wessner M; Sadowski G
Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamic Modeling of the Amorphous Solid Dispersion-Water Interfacial Layer and Its Impact on the Release Mechanism.
Dohrn S; Kyeremateng SO; Bochmann E; Sobich E; Wahl A; Liepold B; Sadowski G; Degenhardt M
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242781
[TBL] [Abstract][Full Text] [Related]
12. Choosing Appropriate Solvents for ASD Preparation.
Luebbert C; Real D; Sadowski G
Mol Pharm; 2018 Nov; 15(11):5397-5409. PubMed ID: 30335401
[TBL] [Abstract][Full Text] [Related]
13. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
[TBL] [Abstract][Full Text] [Related]
14. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
[TBL] [Abstract][Full Text] [Related]
15. Amorphous-Amorphous Phase Separation in API/Polymer Formulations.
Luebbert C; Huxoll F; Sadowski G
Molecules; 2017 Feb; 22(2):. PubMed ID: 28212300
[TBL] [Abstract][Full Text] [Related]
16. Adding a New Dimension to the Amorphous Solid Dispersion Phase Diagram: Studying Dissolution Kinetics of Crystalline Drugs in a Polymer Matrix Using Temperature Dependent XRPD and DSC.
Seiler VK; Theil F; Nagel N; van Lishaut H
J Pharm Sci; 2022 Sep; 111(9):2496-2504. PubMed ID: 35405124
[TBL] [Abstract][Full Text] [Related]
17. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
[TBL] [Abstract][Full Text] [Related]
18. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
Veith H; Wiechert F; Luebbert C; Sadowski G
Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
[TBL] [Abstract][Full Text] [Related]
19. Phase behavior of pharmaceutically relevant polymer/solvent mixtures.
Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
Int J Pharm; 2020 Mar; 577():119065. PubMed ID: 31988034
[TBL] [Abstract][Full Text] [Related]
20. Influence of copolymer composition on the phase behavior of solid dispersions.
Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
